Our Company Vision & Values

Our overall company vision is to improve wellbeing through innovation. We achieve this through our mission to improve patient care by using the latest digital technologies to transform the speed and accuracy of diagnosis. Together, the vision and values provide strategic direction for the organisation, informing its current and future business strategies. At Cirdan our values are at the heart of our business and should be the building blocks of our continued growth and development.




Innovation is at the heart of Cirdan and as a company our vision is to “improve wellbeing through innovation.” This vision drives our product development and all business activities.

Our Track Record

Established in 2010, Cirdan is a leading provider of informatics software and imaging solutions that enhance and speed up the diagnosis of patients. Headquartered in the UK, with offices in Canada and Australia, Cirdan is recognised as one of the leading suppliers of laboratory information systems worldwide. Our innovative systems are currently helping to increase efficiency and streamline operations in multiple public and private clinical laboratories across the world.

Following the acquisition of Belfast-based Philips Digital and Computational Pathology business (formerly known as PathXL) in July 2020 Cirdan has added digital pathology education software to its product portfolio and enhanced its digital pathology and artificial intelligence capabilities, further strengthening its position as a leader in the pathology market.

Innovation is at the heart of Cirdan and as a company our vision is to “improve wellbeing through innovation.” This vision drives our product development and all business activities.

Founded by Industry Leaders

Dr. Hugh Cormican, CEO

Dr Hugh Cormican, originally studied Physics at Queens University Belfast and is a Fellow of the Institute of Physics.

During his PhD studies he became involved in the start-up of Andor Technology. Hugh acted as the Chief Executive Officer (CEO) of Andor Technology from its inception in 1989 and guided Andor through its successful stock market listing in December 2004.

In 2008 Hugh moved to the US to seek medical imaging opportunities and took up the post as acting CEO for Bioptics Inc in Tuscon, Arizona.

Hugh returned to Northern Ireland in 2010 and became a founding member and CEO of Cirdan. As the CEO, Hugh orchestrated the successful purchase of the ULTRA LIS from GE Healthcare in 2013 and has helped grow the company to over 50 employees.

Stephen Dunniece, Chief Officer Imaging

Stephen Dunniece is CO for Imaging where he helps lead product design and development with the aim of introducing new products and technologies that truly meet the increasing needs of today’s healthcare service providers.

Before helping co-found Cirdan, Stephen worked at Andor Technology as senior R+D engineer leading the delivery of several generations of product which helped underpin Andor’s success.

Beyond upcoming new product introductions which improve and extend Cirdan’s offerings in visible and x-ray imaging, Stephen looks forward to the next generation of products which will rapidly provide information directly related to the pathological state of specimens which will greatly aid outcomes in the treatment of cancer.

Board Members

Dr James (J G) Doherty, Chairman of the Board

Dr James (JG) Doherty is an experienced entrepreneur. He founded and was CEO of Amphion Semiconductor, an advanced microchip design company co-headquartered in Belfast and San Jose, and which was acquired by Conexant Systems Inc. Previously, Dr Doherty had been on the academic staff of Queen’s University Belfast, and was a non-executive director of QUBIS, the University’s venture capital vehicle. He has chaired the boards of several high technology start-ups in Northern Ireland.

Denise Sidhu, Board Member

Denise is a Partner and Director at Kernel Capital. Denise joined the Kernel Capital team in 2001 and is a Venture Capital executive with significant operational, commercial and financial experience. Denise is an active board member across a number of the Kernel Capital portfolio investees. Prior to joining Kernel in 2001, Denise’s corporate finance experience varied from debt financing as Head of Finance in Ulster Bank Commercial Finance Limited.

Neil Simms, Board Member

Neil is Finance Director and Investment Director at Clarendon Fund Managers Ltd, who manage Co-Fund NI. A 20 year career in venture capital he has either led or been heavily involved in negotiating and completing multiple investment rounds and exits in over twenty Northern Ireland based SMEs, across a broad range of sectors. This includes a number of innovative and successful med-tech companies.

Frank Bryan OBE, Board Member

Frank Bryan is a Chair, senior executive coach and business mentor, with a portfolio of non-exec. board directorships. Prior to this he was Managing Director of his own tech-based contract engineering business for 25 years, a Non-Exec. Director on the UK National Board for the Institute of Directors, and a Trustee on a number of local charity boards.